Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Elevation Oncology | ELEV | Nov 26, 2024 | 0.63 | +2.89 |
Eli Lilly | LLY | Nov 26, 2024 | 789.32 | +4.55 |
Elicio Therapeutics | ELTX | Nov 26, 2024 | 4.88 | -2.40 |
Eliem Therapeutics | ELYM | Nov 26, 2024 | 5.11 | 0.00 |
Ellington Financial | EFC | Nov 26, 2024 | 12.37 | -0.88 |
Ellington Financial | EFC-B | Nov 26, 2024 | 23.20 | 0.00 |
Ellington Financial A Pref | EFC-A | Nov 26, 2024 | 25.20 | -0.40 |
Ellington Financial D Pref | EFC-D | Nov 26, 2024 | 23.34 | 0.00 |
Ellington Financial E Pref | EFC-E | Nov 26, 2024 | 25.50 | +0.12 |
Ellington Financial Pref | EFC-C | Nov 26, 2024 | 25.06 | +0.24 |
Ellington Residential Mortgage REIT | EARN | Nov 26, 2024 | 6.75 | +0.30 |
Ellomay Capital | ELLO | Nov 26, 2024 | 16.30 | -1.15 |
Ellsworth Growth | ECF | Nov 26, 2024 | 9.83 | -0.20 |
Ellsworth Growth A | ECF-A | Nov 26, 2024 | 24.03 | -0.07 |
Elme Communities | ELME | Nov 26, 2024 | 16.69 | +1.77 |
Eltek | ELTK | Nov 26, 2024 | 11.04 | +1.05 |
Elutia | ELUT | Nov 26, 2024 | 4.00 | -3.85 |
Embecta | EMBC | Nov 26, 2024 | 18.70 | +29.77 |
Embotelladora Andina ADR | AKO-A | Nov 26, 2024 | 13.16 | +0.37 |
Embotelladora Andina ADR | AKO-B | Nov 26, 2024 | 17.63 | -1.23 |
Embrace Change Acquisition | EMCG | Nov 26, 2024 | 11.65 | 0.00 |
Embrace Change Acquisition Unit | EMCGU | Nov 26, 2024 | 11.65 | 0.00 |
Embraer ADR | ERJ | Nov 26, 2024 | 40.00 | +2.80 |
EMCOR Group | EME | Nov 26, 2024 | 514.78 | +0.74 |
Emcore | EMKR | Nov 26, 2024 | 2.97 | -1.00 |
Emerald Holding | EEX | Nov 26, 2024 | 4.83 | -1.02 |
Emeren ADR | SOL | Nov 26, 2024 | 1.82 | -6.19 |
Emergent BioSolutions | EBS | Nov 26, 2024 | 10.03 | +1.83 |
Emerson Electric | EMR | Nov 26, 2024 | 133.00 | +0.19 |
Emerson Radio | MSN | Nov 26, 2024 | 0.45 | +3.56 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.